SEC Form 4 · accession 0001246360-16-006343
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heyward R Donigan
Director
Period of report
Jul 15, 2016
Accepted (ET)
Jul 19, 2016 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $21.73 | Jul 15, 2016 | A | 14,366 | A | Aug 15, 2016 | Jul 14, 2023 | Common Stock | 14,366 | 14,366 | D |
Explanation of responses
- F1The stock option becomes exercisable in 36 equal monthly installments beginning August 15, 2016.